Search Results 101-110 of 14843 for Hepatitis C
Patients who have an aggressive, recurring hepatitis C infection following liver transplant, will be given sofosbuvir combined with ribavirin, and pegylated ...
During her three-day checkup, she was told that X-rays had found a cancerous tumor on her liver. So, instead of talking about her Hepatitis C treatments, she ...
Hepatitis C, one of several hepatitis viruses, is generally considered to be the most serious. Left untreated, hepatitis C can cause serious liver damage ...
... hepatitis C infection. "The liver scarring from hepatitis C can take 20 to 30 years to develop into cancer," Dr. Kim says. "We're now seeing cancer patients ...
Develop advanced imaging technology for monitoring liver inflammation during direct-acting antiviral treatment for hepatitis C, and evaluate risks of severe ...
Hepatitis C is spread by blood and becomes a long-term, chronic infection for 70% to 85% of infected people. Chronic hepatitis C can result in long-term ...
A Study Comparing Measurements of Response to Antiviral Treatments for Liver Transplant Patients that have Recurrent Hepatitis C ... Hepatitis C virus.
Chronic hepatitis C can result in long-term health problems, but the majority may not be aware of the infection. "Hepatitis is one of those hidden illnesses ...
A Study To Compare The Effectiveness And Safety Of ABT-493/ABT-530 To Sofosbuvir Given Together With Declatasvir In Adults With A Chronic Hepatitis C Virus ...
Stacey Rizza outlines the risk of being infected with hepatitis C, especially for people born between 1945 and 1965. Here's the Mayo Clinic Radio podcast ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Mayo Clinic researchers drive discoveries that improve detection, diagnosis and treatment. Your quick message to them means so much.